Keyword index


21st Century, 1

acetoacetates, 511

acute coronary events, 217

acute intermittent porphyria, 27, 319

acute myocardial infarction, 61, 159

administrative database, 397

aetiology, 171

aged, 499

alcohol, 453

allogeneic bone marrow transplantation, 185

allogeneic peripheral blood stem cell transplantation, 185

angina pectoris, 61

angioplasty, 126

anorexia nervosa, 137

antiobesity agents, 245

antioxidants, 377

antiphospholipid antibodies, 519

arterial hypertension, 7

atherosclerosis, 377

attack rate, 159

attitudes, 279

autnomic nervous system, 21

autologous hematopoietic stem cell transplantation, 185

autonomic neuropathy, 481

β2-adrenergic receptor gene, 239

B-cell chronic lymphocytic leukaemia, 343

behaviour modification, 299

bias, 447

biomarkers, 447

blood pressure, 239

blood presure monitoring (ambulatory), 501

B-mode ultrasonography, 377

body fat distribution, 239

brain natriuretic peptide, 309

breast neoplasms, 143

cafestol, 211

calcification, 85

cancer, 171

cardiac arrest, 53

cardioascular diseases, 245

cardiomyopathy, 85

cardiopulmonary exercise test, 309

cardiopulmonary resuscitation, 279

cardiovascular, 455

cardiovascular diseases, 490

cardiovascular risk factors, 67, 203, 479

carotid arteriolsclerosis, 7

case fatality, 159

case–control study, 77

catastrophic antiphospholipid syndrome, 519

catecholamines, 85

causes of death, 333

change, 95

cigarettes, 103

clinical randomized trials, 377

clinical trial, 111

coagulation, 151

complications, 387

confounding, 447

congestive heart failure, 309

coronary atherosclerosis, 151

coronary heart disease, 143, 326

cost, 397

cost drivers, 387

cost-of-illness, 387

C-reactive protein, 406

creatinine, 511

cytokines, 61

decision-making, 279

diabetes mellitus, 13, 119, 483

diabetes mellitus type 1, 67

diabetes mellitus type 2, 492

diabetic ketoacidosis, 511

diagnosis codes, 397

dialysis, 21

diffusion capacity, 137

direct medical costs, 387

discharges, 397

disease activity, 33

DNA amplification, 271

drug delivery systems, 357

drug therapy, 245

dyslipidaemia, 203

electrocardiography, 126

emphysema, 137

endothelial damage, 316

epidemiological study, 103

epidemiology, 13

Escherichia coli, 263

ethics, 279

evidence, 455

familial hyperlipidaemia, 111

fever of unknown origin, 415

folic acid, 223

French-press coffee, 211

gamma-glutamyl transpeptidase activity, 230

gastroretentive delivery systems, 357

gene diagnostics, 271

gene ethics, 271

genetic epidemiology, 77

genetic prediction, 271

genetics, 1

globalization, 1

glucose, 435

glucose intolerance, 103

growth hormone, 525

haemolytic uraemic syndrome, 263

HDL cholesterol, 203

health care systems, 95

heart failure, 279

heart rate variability, 21

heparin, 287

hepatocellular carcinoma, 292

hereditary haemorraghic telangiectasia, 255

hip fractures, 143

HIV-seronegative, 343

HMG-CoA reductase inhibitors, 111

homocysteine, 217, 223

hormone replacement therapy, 143

hydroxybutyrates, 511

hypercholesterolaemia, 42

hyperhomocysteine, 223

hypertension, 203, 230, 455, 501

implants, 357

incident case–referent study, 475

infections, 171

inflammation, 61

inflammation marker, 406

in-hospital, 53

insulin, 299, 435

intensified insulin therapy, 333

interaction, 475

intima–media thickness, 42

IS6110 insertion element, 415

ischemia, 126

kahweol, 211

ketones, 511

kinking, 7

late complications, 333

LDL cholesterol, 203

LDL particle size, 42

left ventricular dysfunction, 309

leptin, 299

leptin receptor, 77

leptin receptor gene, 435

Libman–Sacks endocarditis, 519

life expectancy, 1

lipids, 435, 455

liver transplantation, 292

long-term survival, 425

malnutrition, 137

mass screening, 492

medical education, 95

medical ethics, 1, 463

medical records, 397

men, 239

MEN-I, 525

metabolic syndrome, 230

metabolism, 239

methionine loading test, 223

middle age, 143

models: theoretical, 143

molecular epidemiology, 447, 77

mortality, 159, 292, 333

multi-organ failure, 519

multiple myeloma, 185

mutation detection, 271

Mycobacterium genavense, 343

Mycobacterium tuberculosis, 415

myocardial infarction, 119, 217, 316, 406, 425

neurology, 255

neuropathy, 27

normolipidaemic subjects, 211

obesity, 13, 245, 299

osmotic pumps, 357

outcome, 287

out-of-hospital, 53

overfeeding, 435

patient autonomy, 279

patient compliance, 357

patient recruitment, 463

platelets, 316

polymerase chain reaction, 415

polymorphism, 239, 435

polyneuropathy, 21

population, 483

population studies, 217, 377

prevention, 455

primary biliary cirrhosis, 292

prognosis, 53, 119, 333

progressive, 287

prospective, 13

prospective studies, 77, 217

public health, 171

pulmonary arteriovenous malformations, 255

pulmonary function test, 137

pyridoxine, 223

QT dispersion, 126

randomized controlled trials, 463

reference values, 501

registers, 159

renal insufficiency, 319

research, 1

research ethics, 463

risk factors, 111, 230, 406, 492

ROC curve, 151

sarcoidosis, 33

serum bilirubin, 292

serum lipid transfer proteins, 211

Seven Countries Study, 326

snoring, 13

social factors, 475

socioeconomic, 425

soluble TNF receptor, 33

statistical power, 447

stature, 326

stroke, 287, 475

T vector loop, 126

thrombolysis, 119, 316

thyroid function, 299

time trends, 425

TNF-α, 67

tobacco use, 103

transdermal drug delivery, 357

transitory ischaemic attack, 7

transoesophageal echocardiography, 519

trial participation, 463

triglycerides, 203

type 1 diabetes, 333

type 2 diabetes, 77, 103, 245, 387

unstable coronary artery disease, 151

uraemia, 21

urinary albumin excretion, 483

urinary tract infection, 263

ursodeoxycholic acid, 292

validation study, 397

vasospasm, 319

ventricular repolarization, 126

verotoxin/Shiga-like toxin, 263

vitamin E, 316

weight loss, 245

women, 151

Ancillary